Trial Profile
Enoxaparin sodium versus fondaparinux sodium for the prevention of postoperative thrombosis in Japanese patients who have undergone total hip replacement
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2011
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary) ; Fondaparinux sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Therapeutic Use
- 29 Mar 2011 New trial record